Mefanorm Suspension contains Mefenamic Acid 100mg/5ml, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the management of mild to moderate pain and inflammation associated with conditions such as dysmenorrhea, musculoskeletal disorders, and dental pain. Mefenamic Acid exerts its therapeutic effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins, which are mediators of pain and inflammation. This suspension formulation allows for accurate dosing in pediatric and adult patients who require an oral liquid preparation. Mefanorm Suspension is typically administered orally with food to minimize gastrointestinal irritation, with dosage and duration tailored according to the severity of symptoms and patient response. Common adverse effects may include gastrointestinal discomfort, nausea, vomiting, and, rarely, hypersensitivity reactions. Caution is advised in patients with a history of peptic ulcers, renal or hepatic impairment, and cardiovascular disease. It is contraindicated in individuals with known hypersensitivity to mefenamic acid or other NSAIDs. Use during pregnancy and lactation should be avoided unless clearly necessary. Mefanorm Suspension should be used under medical supervision, with adherence to prescribed dosage to optimize therapeutic outcomes and minimize potential adverse effects.